decisionhealth Newsletters, Answer Books - 2007 Issue 10 (October)
National_Coverage_Determinations_Manual / Lumbar Artificial Disc Replacement (LADR)
Subscribe or sign in to view the full article.
Article Overview
This Medicare coverage article addresses lumbar artificial disc replacement within the National Coverage Determinations Manual. It outlines the general clinical context, the national non-covered indications, and other coverage considerations tied to effective dates, patient age, and local contractor decision-making. It is useful for coders, billing staff, compliance teams, and clinicians who need to understand how CMS coverage policy applies to this lumbar spine procedure.
Why This Topic Matters
Coverage policy for lumbar artificial disc replacement can affect whether services are reimbursable under Medicare, especially when age-based and date-based policy differences apply. Understanding the scope of the NCD helps organizations avoid denials and align documentation, billing, and coverage review processes with CMS guidance.
Article Sections
-
A. General
Provides a broad overview of the lumbar artificial disc replacement procedure and its clinical context. It also references the setting in which the procedure is considered and the spinal levels discussed in the policy.
-
B. Nationally Covered Indications
States the national coverage status for this policy section. This portion indicates whether the service is addressed as covered under the NCD.
-
C. Nationally Non-Covered Indications
Describes the periods and patient groups addressed under national non-coverage. It focuses on Medicare coverage status changes and the affected time frames.
-
D. Other
Addresses additional coverage context not included in the main covered or non-covered sections. It includes local contractor responsibility and a note about investigational device exemption-related trial coverage.
What You Will Learn
- The Medicare coverage framework for lumbar artificial disc replacement.
- How the policy distinguishes national non-coverage from contractor-level decisions.
- Which effective dates are relevant to the coverage discussion.
- How investigational device exemption-related trial coverage is referenced in the policy.
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Healthcare providers
- Revenue cycle teams
- Utilization review staff
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com